Skip to main content
EirGenix logo

EirGenix — Investor Relations & Filings

Ticker · 6589 ISIN · TW0006589005 TW Manufacturing
Open in API
Filings indexed 41 across all filing types
Latest filing 2026-05-19 Transaction in Own Shar…
Country TW Taiwan
Listing TW 6589

About EirGenix

http://www.eirgenix.com

EirGenix, Inc. operates under a dual-engine business model, integrating Contract Development and Manufacturing Organization (CDMO) services with the development of proprietary biologics. The company provides comprehensive solutions spanning cell line development, process optimization, analytical testing, and cGMP-compliant manufacturing for both mammalian and microbial cultures. Its technical infrastructure includes large-scale production capabilities with multiple 2,000-liter single-use bioreactors and advanced continuous manufacturing platforms. EirGenix’s internal pipeline focuses on high-quality biosimilars, notably HER2-targeted therapies for breast cancer, including Trastuzumab biosimilar assets. Additionally, the company produces specialty products such as the CRM197 carrier protein and diagnostic tools. By leveraging integrated development and manufacturing expertise, EirGenix delivers cost-effective biopharmaceutical solutions to support global healthcare needs.

Recent filings

Filing Released Lang Actions
第2次庫藏股基本資料
Transaction in Own Shares Classification · 94% confidence The document is a formal company announcement detailing a share buyback program (“買回股份”), including board resolution date, purpose, number of shares, repurchase period, price range, and historical repurchase data. This matches the definition for Transaction in Own Shares (share repurchase reporting).
2026-05-19 Chinese
第2次庫藏股基本資料
Transaction in Own Shares Classification · 92% confidence The document is a standard disclosure from the Taiwan Stock Exchange system regarding the company’s second application for a share buyback, detailing share repurchase purposes, amounts, dates, and board resolution. This matches a ‘Transaction in Own Shares’ filing for share repurchases.
2026-05-18 Chinese
公告本公司臨時董事會決議買回庫藏股
Transaction in Own Shares Classification · 96% confidence The document is a regulatory disclosure by a listed company (6589 Tai-Kang Biotechnology) announcing its Board resolution to repurchase treasury shares, detailing the number of shares, price range, period, and related buyback history. This matches the definition of Transaction in Own Shares (share repurchase).
2026-05-14 Chinese
第2次庫藏股基本資料
Transaction in Own Shares Classification · 95% confidence The document is an official share buyback announcement filed with the local exchange (“申請買回股份”), detailing the number of shares, buyback period, price range, source of funds, board resolution, and past execution. This fits precisely the definition of a Transaction in Own Shares (share repurchase) filing.
2026-05-14 Chinese
115年第1季財務報告書 — 202601_6589_AI1.pdf
Interim / Quarterly Report Classification · 98% confidence The document is titled “合併財務報告暨會計師核閱報告 民國115年及114年第一季” and contains full interim consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow, detailed notes) and an auditor’s review under IFRS 34 “Interim Financial Reporting”. It covers a period shorter than a full fiscal year (first quarter) and includes substantive financial data and analysis. Therefore it is an Interim / Quarterly Report. Q1 2026
2026-05-14 Chinese
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 75% confidence The document is from the Taiwanese Market Observation Post System (“公開資訊觀測站”) and provides detailed financial schedules for the company’s 115th year Q1 (first quarter) filings, including actual investment amounts, carrying amounts under the equity method, and recognized investment profit or loss. It contains substantive financial data for an interim period, not merely an announcement or a link to a report. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-14 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.